Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Diclofenac Sodium; Misoprostol Patent Expiration

Diclofenac Sodium; Misoprostol was first introduced by Pfizer Inc in its drug Arthrotec on Dec 24, 1997. 8 different companies have introduced drugs containing Diclofenac Sodium; Misoprostol.


Diclofenac Sodium; Misoprostol Patents

Given below is the list of patents protecting Diclofenac Sodium; Misoprostol, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Arthrotec US5601843 Pharmaceutical tablet composition Feb 11, 2014

(Expired)

 Pfizer



Diclofenac Sodium; Misoprostol's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Diclofenac Sodium; Misoprostol Generic API Manufacturers

Several generic applications have been filed for Diclofenac Sodium; Misoprostol. The first generic version for Diclofenac Sodium; Misoprostol was by Actavis Laboratories Fl Inc and was approved on Jul 9, 2012. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Jun 12, 2023.

Given below is the list of companies who have filed for Diclofenac Sodium; Misoprostol generic, along with the locations of their manufacturing plants worldwide.